Quarterly report · Q2

Period2023-01-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥18m2023-01-01 → 2023-06-30StandaloneNet sales
Revenue¥374m2022-01-01 → 2022-12-31StandaloneNet sales (5-year summary)
Revenue¥333m2022-01-01 → 2022-06-30StandaloneNet sales
Operating income−¥364m2023-01-01 → 2023-06-30StandaloneOperating income
Operating income−¥97m2022-01-01 → 2022-06-30StandaloneOperating income
Ordinary income−¥363m2023-01-01 → 2023-06-30StandaloneOrdinary income
Ordinary income−¥433m2022-01-01 → 2022-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥76m2022-01-01 → 2022-06-30StandaloneOrdinary income
Profit before tax−¥363m2023-01-01 → 2023-06-30StandaloneIncome before income taxes
Profit before tax−¥114m2022-01-01 → 2022-06-30StandaloneIncome before income taxes
Net income−¥365m2023-01-01 → 2023-06-30StandaloneProfit loss
Net income−¥474m2022-01-01 → 2022-12-31StandaloneNet income loss (5-year summary)
Net income−¥115m2022-01-01 → 2022-06-30StandaloneProfit loss
Total assets¥4.4bnat 2023-06-30StandaloneAssets
Total assets¥4.8bnat 2022-12-31StandaloneAssets
Total assets¥2.9bnat 2022-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥976mat 2023-06-30StandaloneLiabilities
Total liabilities¥1.0bnat 2022-12-31StandaloneLiabilities
Net assets / equity¥3.4bnat 2023-06-30StandaloneNet assets
Net assets / equity¥3.8bnat 2022-12-31StandaloneNet assets
Net assets / equity¥1.9bnat 2022-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥4.1bnat 2023-06-30StandaloneCash and deposits
Cash and deposits¥4.4bnat 2022-12-31StandaloneCash and deposits
Cash & equivalents¥3.1bnat 2023-06-30StandaloneCash and cash equivalents
Cash & equivalents¥3.4bnat 2022-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.6bnat 2022-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.6bnat 2021-12-31dStandaloneCash and cash equivalents
Operating cash flow−¥316m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥404m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥43m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥11m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥431m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥261m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in investment activities
Financing cash flow−¥53m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥2.7bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥319m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-46.732023-01-01 → 2023-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-25.162023-04-01 → 2023-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-177.672022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-203.612022-01-01 → 2022-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-185.422022-04-01 → 2022-06-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio77.7%at 2023-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio78.3%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio66.6%at 2022-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued7,813,800at 2023-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued7,773,300at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,211at 2022-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 422
ItemContextValueUnit
Net increase decrease in cash and cash equivalentsPrior1YTDDuration_NonConsolidatedMember14955000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration_NonConsolidatedMember-380706000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember1613040000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember3437307000JPY
Cash and cash equivalentsPrior1QuarterInstant_NonConsolidatedMember1627996000JPY
Cash and cash equivalentsCurrentQuarterInstant_NonConsolidatedMember3056601000JPY
Directors compensations sgaPrior1YTDDuration_NonConsolidatedMember57900000JPY
Directors compensations sgaCurrentYTDDuration_NonConsolidatedMember57937000JPY
Salaries allowances and bonuses sgaPrior1YTDDuration_NonConsolidatedMember18680000JPY
Salaries allowances and bonuses sgaCurrentYTDDuration_NonConsolidatedMember21277000JPY
Rents sgaPrior1YTDDuration_NonConsolidatedMember27645000JPY
Rents sgaCurrentYTDDuration_NonConsolidatedMember12519000JPY
Research and development expenses sgaPrior1YTDDuration_NonConsolidatedMember137456000JPY
Research and development expenses sgaCurrentYTDDuration_NonConsolidatedMember182566000JPY
Business consignment expenses sgaPrior1YTDDuration_NonConsolidatedMember14713000JPY
Business consignment expenses sgaCurrentYTDDuration_NonConsolidatedMember30083000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の4の7第1項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-08-14
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第14期第2四半期(自 2023年4月1日 至 2023年6月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社サイフューズ
Company name in english cover pageFilingDateInstantCyfuse Biomedical K.K.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役 秋枝 静香
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都港区三田三丁目5番27号 住友不動産三田ツインビル西館
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03-6435-1885(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役 CFO 経営管理部長 三條 真弘
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都港区三田三丁目5番27号 住友不動産三田ツインビル西館
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03-6435-1885(代表)
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役 CFO 経営管理部長 三條 真弘
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE38156
Fund codeFilingDateInstant-
Security codeFilingDateInstant48920
Filer name in japaneseFilingDateInstant
Original text (Japanese)株式会社サイフューズ
Filer name in englishFilingDateInstantCyfuse Biomedical K.K.
Fund name in japaneseFilingDateInstant-
Fund name in englishFilingDateInstant-
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstantfalse
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstant-
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte
Current fiscal year start dateFilingDateInstant2023-01-01
Current period end dateFilingDateInstant2023-06-30
Type of current periodFilingDateInstantQ2
Current fiscal year end dateFilingDateInstant2023-12-31
Previous fiscal year start dateFilingDateInstant2022-01-01
Comparative period end dateFilingDateInstant2022-06-30

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-06-30pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-06-30pass